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In the yeast Saccharomyces cerevisiae, three enzymes of the sterol biosynthetic pathway, namely Erg1p, Erg6p and Erg7p, are located in
lipid particles. Whereas Erg1p (squalene epoxidase) is also present in the endoplasmic reticulum (ER) to a significant amount, only traces of
Erg6p (sterol C-24 methyltransferase) and Erg7p (lanosterol synthase) are found in the ER. We have chosen these three Erg-proteins as
typical representatives of lipid particle proteins to study targeting to their destination. Lipid particle proteins do not contain obvious targeting
motifs, but the only common structural feature is the presence of one or two hydrophobic domains near the C-termini. We constructed
truncated versions of Erg1p, Erg6p and Erg7p to test the role of these hydrophobic domains in subcellular distribution. Our results
demonstrate that lack of the hydrophobic domains prevents at least in part the association of the proteins with lipid particles and causes their
retention to the ER. This result strongly supports the view that ER and lipid particles are related organelles.
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Nearly all organisms, including yeast, plants and mam- synthesized TAGs accumulate in the hydrophobic region ofmals, as well as some prokaryotes, have the capacity to store
neutral lipids in intracellular lipid droplets. These droplets
consist of a highly hydrophobic core of triacylglycerols
(TAGs) and/or steryl esters, surrounded by a phospholipid
monolayer with only a few proteins embedded [1]. The
biogenesis of lipid particles including targeting of proteins
to the particles’ surface, however, is still poorly understood.
Common targeting motifs of the primary sequence were
neither found for typical mammalian lipid droplet proteins,
such as perilipins or adipose differentiation-related protein
(ADRP), nor for polypeptides of plants or yeast, although
plants with their oil-body-associated proteins, the so-called
oleosins, have been extensively studied for targeting signals.
Oleosins were postulated to play a role in preventing aggre-
gation of storage lipids during seed maturation-desiccation
[2,3] and in the biogenesis of the oil bodies themselves [4].
One model referring to the latter process suggests that newly0005-2736/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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E-mail address: guenther.daum@tugraz.at (G. Daum).the endoplasmic reticulum (ER) membrane between the two
phospholipid layers. Eventually, a droplet of TAGs sur-
rounded by a phospholipid monolayer disconnects and is
released into the cytosol [5–7]. The fact that the site of TAG
synthesis in plants is the ER [8,9] strongly supports the
budding model and made it widely accepted. However, the
crucial question remains: how do proteins reach the oil
bodies? It was suggested that oleosins are synthesized on
membrane-bound ribosomes [10,11] and cotranslationally
inserted into microsomal membranes [12–14] in a signal-
recognition-particle-dependent manner [15]. Subsequent re-
quirement for a functional Sec61 translocon to mediate the
correct insertion of the proteins into the membrane was
demonstrated by Beaudoin et al. [14]. Thus, it seems likely
that synthesis of oleosins and TAGs occurs within the same
subcellular compartment and, moreover, that the process may
be coordinated to facilitate the assembly of the oil body
[3,4,16,17]. This hypothesis was supported by a study which
demonstrated synthesis and occurrence of oleosins in ‘‘light’’
fractions of the ER enriched in TAG-synthesizing enzymes
[9]. Oleosins show a characteristic three-domain structure. A
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acid residues is flanked by two amphipathic regions of more
variable nature [18,19]. The importance of the hydrophobic
domain, in particular of the so-called ‘‘proline-knot’’, for the
correct targeting of oleosins is generally accepted.
Identification of the major proteins of lipid particles from
Saccharomyces cerevisiae [20] was a prerequisite to study
targeting of polypeptides to yeast lipid particles. We have
chosen three sterol-synthesizing enzymes, Erg1p, Erg6p and
Erg7p, to address this question for two reasons: (i) these
three proteins, unlike other enzymes of the sterol biosynthe-
sic pathway, which are associated with the ER [21], are either
localized exclusively to lipid particles or distributed between
the ER and lipid particles [22–24]; (ii) the fact that most
steps of sterol biosynthesis occur in the ER, while some
enzymes of this pathway are localized in lipid particles,Fig. 1. Subcellular localization of overexpressed full-length proteins and truncated
stretches removed in the truncates are marked in gray in the Kyte–Doolittle hydro
described in the text. The appearance of bands with lower molecular mass (upper
overexpressed. lp: lipid particles; 30m: 30.000 g microsomes; 40m: 40.000 graises the interesting question as to the collaborative inter-
action of these two compartments in sterol synthesis.
Following the idea that hydrophobic regions of polypep-
tides may be responsible for their anchoring to lipid particles,
we studied the influence of such C-terminal domains of
various lengths on the targeting of Erg1p, Erg6p and Erg7p
to lipid particles. The subcellular distribution of the truncated
constructs was determined by cell fractionation and Western
blot analysis.
The haploid wild-type yeast strain S. cerevisiae FY1679
(MATa ura 3-52 trp1 D63 leu2 D1 his D200) and the diploid
wild-type strain FY1679 (MATa/a ura 3-52/ura 3-52 leu2D1/
LEU2 his D200/HIS3 trp1 D63/TRP1) were used throughout
this study. Cells were grown aerobically at 30 jC in YPD
medium (1% yeast extract, 2% peptone, 2% glucose) or
anaerobically in YPD supplemented with ergosterol andforms of Erg1p (A), Erg6p (B) and Erg7p (C). Positions of the hydrophobic
pathy plots. Cell fractionation and Western blot analysis were performed as
lane) is probably due to degradation of full-length Erg1p and Erg6p when
microsomes; v: vacoules.
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using an AnaeroGen sachet [Oxoid] in a 3.5-l sealed jar.
E. coli XL1-Blue and Top10F served as hosts for
plasmids used in this study. Cells were grown in LB
medium (1% tryptone, 0.5% yeast extract, 0.5% NaCl)
containing 100–200 mg/l ampicillin [Carl Roth]. Yeast
transformants bearing recombinant plasmids (Erg1p- and
Erg7p-truncates in the FY1679 background and Erg6p-
truncates in an Derg6 strain with FY1679 background) were
grown on leucine-free minimal medium (YNB).
Kyte–Doolittle hydropathy plots [25] of Erg1p [26],
Erg6p and Erg7p (Fig. 1) were used to define the positions
of the hydrophobic domains to be removed from the pro-
teins. For the construction of ERG1 and ERG6 deletion
alleles, PCR products with additional recognition sites in-
troduced either at the 5Vor the 3Vend were used to replace the
corresponding full-length DNA fragments of ERG1 and
ERG6 genes in YEp351. To remove the hydrophobic
sequences within Erg7p, gene Splicing by Overlap Extension
(SOE) [27] was applied. Primers used for amplification of
the DNA fragments for all constructs are listed in Table 1.
The correct structure of all constructs was confirmed by
DNA sequencing. To test the functionality of Erg1p and
Erg7p truncates, Derg1 and Derg7mutants were transformed
with the respective recombinant plasmids, and transformants
were assayed for ergosterol auxotrophy. In the case of Erg6p-
truncates, an Derg6mutant transformed with YEp351 encod-
ing the Erg6p-fragments was tested for the occurrence of
characteristic sterol intermediates [24]. None of the truncated
versions of the three Erg-proteins, however, restored the
original function of the enzymes (data not shown).
Microsomes, lipid particles and vacuoles were isolated by
published procedures [28]. Protein quantification [29] withTable 1
Primers for amplification of ERG1, ERG6 and ERG7 genes and truncated alleles
Primer (5V! 3V)
ERG1 (fw) See Ref. [26]
ERG1 (rev) See Ref. [26]
ERG1-28aa (fw) CATTGAAAATTATATA
ERG1-28aa (rev) CATTGGTTAACCCAAGAAAC
ERG1-55aa (fw) See ERG1-28aa
ERG1-55aa (rev) TCAATTGTTAACGCTTTGGC
ERG6 (fw) TATGCAGAGCTAAAGGTACTGTGCTTAATC
ERG6 (rev) GATTGAGGATCCTATGGAAACAGTTACGATG
ERG6-25aa (fw) GATTTATCTAGAACCAGAAAACGCCGAAAC
ERG6-25aa (rev) ACTATAGCTAGCAATGAACGTGCTATC
ERG6-62aa (fw) GATTTATGGCCACACCAGAAAACGCCGAAACC
ERG6-62aa (rev) See ERG6-25aa
ERG7 (fw)/a TCCCCCCGGGGGGATGCTGCTATTCGTGATTACTGT
ERG7 (rev)/a TCCCCCCAAGCTTGTATTTCTCTTTTCCGTCAACTCA
ERG7-87/139aa (fw) ACAGGTTACCAGTCTGATCCAAAGTTTCGATCTAA
ERG7-87aa (rev) GATCGAAACTTTGGATCAGACTGGTAACCTGTATC
ERG7-139aa (rev) GATCGAAACTTTGGATCAGACTGGTAACCTGTTTG
ERG7 (fw)/b AACAATTTCACACAGGAAACAGCTATGACCATGAT
TCGAGCTCGGTACCCGGGGGGATGCTGCTATTCGT
ERG7 (rev)/b TGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTG
Recognition sites for restriction enzymes are typed in italics, and complementary se
the construction of the truncated alleles, and Erg7 (fw/rev)/b primers for cloningmodifications for lipid particle proteins [22], SDS-PAGE [30]
and Western blot analysis [31] were carried out by published
methods. Proteins were detected by ELISA using polyclonal
anti-Erg1p, anti-Erg6p and anti-Erg7p antibodies, respective-
ly, and peroxidase-conjugated secondary antibodies.
To pinpoint the role of hydrophobic domains which might
direct Erg1p, Erg6p and Erg7p to lipid particles, C-terminally
truncated forms of the three Erg-proteins were constructed on
the basis of Kyte-Doolittle hydropathy plots and investigated
with respect to their subcellular distribution (Fig. 1). Since
truncates of the three Erg-proteins were expressed from a
high-copy-number vector, their localization was compared to
the respective wild-type proteins expressed from the same
vector. As can be seen in Fig. 1, removing the C-terminal
hydrophobic domains caused at least in part a shift of the
truncated proteins from lipid particles to ER fractions. In the
case of Erg1p (Fig. 1A), deletion of 28 amino acids was
already sufficient to retain squalene epoxidase in the micro-
somal fractions and to prevent association with lipid particles.
Similar results were obtained when 55 amino acids were
removed from the C-terminus of Erg1p.
In Erg6p, however, removing one hydrophobic domain
(25aa) did not significantly change the polypeptide’s sub-
cellular distribution (Fig. 1B). In fact, Erg6p-25aa appeared
to have an even stronger preference to associate with lipid
particles than the overexpressed wild-type polypeptide.
Erg6p-62aa, on the other hand, was completely retained in
microsomes and not targeted to lipid particles any more.
Thus, in contrast to Erg1p, the removal of the complete
hydrophobic region at the C-terminus was required to
prevent association of Erg6p with lipid particles.
C-terminal truncation of Erg7p appeared to result in the
least pronounced shift in the distribution of the polypeptidefor cloning into the high-copy-vector YEp351
TAC
C
GGCATTAGGTATGTACAGCAGG
CTTCATCTGTTTACTGACCAAG
AGATTTTTTTATGAATTCGATG
TACGAAT
GATTACT
TAAAACGACGGCCAGTGCCAAGCTTGTATTTCTCTTTTCCGTCAA
quences used for SOE are underlined. Erg7 (fw/rev)/a primers were used for
into YEp351.
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and Erg7p-139aa constructs could still be found in lipid
particles, but a significant amount of the polypeptide was
also associated with the microsomal fractions. Thus, also in
Erg7p the C-terminal hydrophobic domains are required for
complete targeting to lipid particles.
When the hydrophobic stretches at the C-termini of Erg1p,
Erg6p and Erg7p, respectively, were fused to the green
fluorescence protein (GFP), and the localization of these
hybrid proteins was studied by cell fractionation and fluores-
cence microscopy, none of the protein fragments directed
GFP to lipid particles. Hybrid proteins were rather randomly
distributed within the cell (data not shown). Hydrophobic
domains of lipid particle proteins thus seem to be required but
not sufficient for correct targeting to lipid particles, and
additional structural features appear to be important.
The study presented here is an initial attempt to under-
stand the targeting of proteins to yeast lipid particles. Our
results demonstrate that hydrophobic domains near the C-
terminus of the proteins studied, Erg1p, Erg6p and Erg7p,
play an important role in the subcellular distribution of these
polypeptides. Most interestingly, truncation of all three
proteins tested did not result in random distribution within
the cell but rather in a preferential shift from lipid particles to
the ER. This observation supports the idea that proteins
destined to lipid particles may also have a certain affinity
for the ER. The presence of hydrophobic domains and/or
transmembrane spanning domains may be crucial whether or
not a protein will leave the ER during a budding process by
interacting preferentially with the membrane monolayer of
lipid particles. However, additional structural features of the
proteins appear to be equally important for the correct
subcellular targeting to lipid particles. Similar observations
were reported most recently for caveolins by Ostermeyer et
al. [32].
Our results are in line with the idea of simultaneous
budding of neutral lipids and lipid particle proteins from the
ER. Major components of yeast lipid particles, steryl esters
and TAGs, are synthesized to a large amount in the ER
[33,34]. Proteins with hydrophobic domains, but without
transmembrane spanning domains present in the ER, may
accumulate in the vicinity of newly formed neutral lipids.
Once a nascent lipid particle has reached its critical size, the
budding process may take place.
The question as to the physiological relevance of the
sterol biosynthetic pathway being distributed between two
subcellular fractions remains open. The fact that three key
enzymes of yeast sterol biosynthesis, Erg1p, Erg6 and
Erg7p, are subject to this distributive phenomenon sug-
gests that the presence of enzymes of a pathway in two
different organelles may provide an additional regulatory
possibility at the organelle level, which has not yet
received sufficient attention. In the case of Erg1p, the
subcellular localization appears to be even more important
because the portion of this protein present in the lipid
particle fraction is enzymatically inactive, whereas Erg1pof the ER is active [22]. The presence of sterol-synthesiz-
ing enzymes in two organelles also raises the question of
interorganelle migration of sterol intermediates. Similar to
sterols, early intermediates of phospholipid biosynthesis
are also shuffled between lipid particles and the ER [35].
Surface contact of the two organelles or even specific
proteins may play a role in this process. Thus, interplay of
lipid particles and ER may not only be restricted to protein
targeting, but may also affect the regulation of certain lipid
biosynthetic pathways.Acknowledgements
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